Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …

The majority of hematological cancers are age-associated diseases. Therefore, many
patients with hematological malignancies are older and may present with frailty, ie the loss …

Background Age is considered as one of the most important risk-factor for many types of
solid and hematological cancers, as their incidence increases with age in parallel to the ever …

Background Geriatric assessment is increasingly used to assess the health status of older
cancer patients. We set out to assemble all available evidence on the relevance of a …

Chronic myeloid leukemia (CML) is a disease of the hematopoietic stem cell characterized
by a median age at diagnosis of 60–65 years according to most epidemiologic registries …

The impact of age as a poor prognostic factor in chronic myeloid leukemia (CML) has been
well described. In the interferon era, elderly patients diagnosed as having chronic phase …

Clinicians often report that currently available methods to assess older patients, including
standard clinical consultations, do not elicit the information necessary to make an …

The prevalence of chronic myeloid leukemia (CML) is expected to double in the next 15
years. The introduction of imatinib significantly changed the prognosis of CML, challenging …

Background About 40% of all patients with chronic myeloid leukemia are currently old or
very old. They are effectively treated with imatinib, even though underrepresented in clinical …

Simple Summary As life expectancy is increasing, the older population is rapidly growing.
However, older patients with cancer are still underrepresented in clinical trials, making …